"Carrier-drug" layer-by-layer hybrid assembly of biocompatible polydopamine nanoparticles to amplify photo-chemotherapy
Lingyu Lv,Hao Cheng,Zhen Wang,Zhangyi Miao,Feng Zhang,Jie Chen,Gang Wang,Ling Tao,Jianping Zhou,Huaqing Zhang,Yang Ding
DOI: https://doi.org/10.1039/d2nr03200g
IF: 6.7
2022-09-01
Nanoscale
Abstract:Polydopamine (PDA) is capable of wide drug delivery for biomedical applications by virtue of adjustable polymerization process, including surface coating and conjugation. Inspired from the polymerization of dopamine, we introduce a layer-by-layer hybrid co-assembly strategy for incorporation of doxorubicin (DOX) and dopamine to form PDA "carrier-drug" hybrid assembly. The "carrier-drug" hybrid assembly relies on the π-π stacking interaction between drug (DOX) and carrier (PDA), and such stacked layer structure enables PDA nanoparticles with superior drug loading of 58%, which is about 1.7-folds higher than that of DOX surface coating (~35 %). To further improve blood circulation stability and enhance tumor penetration, we herein propose the conjugation of native apolipoprotein A-I (apoA-I) with tumor-homing cyclic peptide iRGD for PDA surface modification. The "carrier-drug" hybrid assembly can respond to triple stimuli of the acidic pH, concentrated reactive oxygen species (ROS) and near-infrared (NIR) light irradiation for realizing site-specific and on-demand drug release. In chemo-photothermal synergy therapy, the "carrier-drug" hybrid assembly perform efficient tumor penetration and accumulation, dramatically suppressing tumor growth and metastasis in a 4T1 orthotopic tumor-bearing mice model at a safe level. Collectively, our findings share new insights into the design of "carrier-drug" hybrid assembly for enhanced chemo-photothermal oncotherapy.
materials science, multidisciplinary,physics, applied,nanoscience & nanotechnology,chemistry